glp 1 patient education Supporting GLP1 Meds with Nutrition - Handout Ontario's Anesthesiologists | ICYMI: Recently,

In patients with diabetes and albuminuria, the HRs for MACE, HHF, and CKD progression with triple combination therapy were estimated to be 0.65 (95% CI 0.550.76), 0.45 (95% CI 0.340.58), and 0.42 (95% CI 0.310.56), respectively, compared with those for conventional therapy alone (renin-angiotensin system inhibitors and classical risk factor management)

Tirzepatide may offer more benefits in adipose tissue remodelling than Semaglutide for instance which doesnt target adipose tissue directly

I also wrote up the SURMOUNT-MAINTAIN dose-reduction trial separately, which addresses what most people want to know once they have hit their target weight

Youre getting specialist-level care at general practitioner prices

Mechanisms in the Brain GLP-1 acts on the hypothalamus, the brains appetite-regulating center